A single center retrospective clinical study revealed the efficacy and safety of tofacitinib in the treatment of ulcerative colitis (UC). This study has clinical reference value but also has some limitations. Previous studies, including this clinical trial, have shown that tofacitinib could be a promising treatment option for UC, but further clinical research is required to prove this point.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525864 | PMC |
| http://dx.doi.org/10.3748/wjg.v30.i40.4386 | DOI Listing |
Publication Analysis
Top Keywords
ulcerative colitis
8
promising treatment
8
treatment option
8
tofacitinib ulcerative
4
colitis promising
4
option single
4
single center
4
center retrospective
4
clinical
4
retrospective clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!